Insider Transactions Reported by 11 Insiders of CTI BIOPHARMA CORP

Location
Seattle, WA

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

CTI BIOPHARMA CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bruce J. Seeley EVP, Chief Operating Officer $399,536 30 Jun 2021
Reed V Tuckson) Director 26 Jun 2023
Adam R. Craig President and CEO, Director 26 Jun 2023
Michael A. Metzger Director 26 Jun 2023
BVF PARTNERS L P/IL Director, Other*, 10%+ Owner 26 Jun 2023
James K. Fong EVP & Chief Commercial Officer 26 Jun 2023
Diane L. Parks Director 26 Jun 2023
David Ross Parkinson Director 26 Jun 2023
Matthew D. Perry Director 26 Jun 2023
Laurent Fischer Director 26 Jun 2023
David Kirske EVP, Chief Financial Officer 26 Jun 2023

Recent Insider Transactions by Companies or Individuals for CTI BIOPHARMA CORP

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.